The latest market report published by Credence Research, Inc. “Global Vein Illuminator Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global vein illuminator market was valued at US$ 32.9 Mn in 2017, and is expected to reach US$ 403.4 Mn by 2026, expanding at a CAGR of 32.7% from 2018 to 2026.
Thrombophlebitis is defined as veins that are red, inflamed and painful. Superficial thrombophlebitis is a condition in which there is a blood clot just beneath the skin surface manifested by swelling and inflammation. Deep vein thrombosis can be fatal as the blood clot can travel to the lungs and cause pulmonary embolism. Medical device manufacturers are striving to develop state of the art vein illuminators to overcome such shortcomings caused due to inaccurate venipuncture. VeinViewer Vision2 (Christie Medical Holdings, Inc.) helps clinicians to view peripheral veins and achieve pre-access, during-access and post-access during venipuncture in geriatric patients. AccuVein has developed a portable, rechargeable, hand-held vein illuminator that finds prominence in neonatal or pediatric intensive care units (ICU).
Infrared technology is dominating the vein illuminator market due to its increasing popularity among physicians using hand held vein illuminating devices. Near infrared technology has been useful in achieving accurate venipuncture in patients receiving chemotherapy and intravenous drug infusion thereby limiting the chances of superficial vein thrombosis and deep vein thrombophlebitis. Ultrasound vein illuminating devices employ the sound waves for generating vein images and it is popular in detecting vascular malformation in narrow vessels.
Intravenous access is currently leading the application segment on account of key parameters such as rising demand for minimally invasive surgical procedures involving intravenous access. Chemotherapy, blood sampling etc. are the other applications of venous access that has a positive impact on the vein illuminator market growth. Blood draw is gaining tremendous importance on account of factors such as growing pathology clinics using blood samples for disease diagnosis. Vein illuminators assist nurses and physicians to perform accurate venipuncture and blood draw procedure in geriatric and obese patients where determination of vascular position is a tedious task.
As per the latest statistics provided by Center for Disease Control and Prevention (CDC) 2016 report, approximately 900,000 U.S. citizens are suffering with thrombophlebitis with a prevalence rate of 1 to 2 per 1000 people. North America currently dominates the vein illuminator market on account of rising prevalence of thrombophlebitis in geriatric and obese population. Excellent treatment guidelines and rising demand for technically innovative products drive the vein illuminator market in Europe. In Asia Pacific the vein illuminator market is determined by the rising patient population receiving intravenous drug infusion treatment and competitive scenario created by the emergence of local players manufacturing low cost vein illuminating devices.
Browse the full report Vein Illuminator Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/vein-illuminator-market
The key players active in the vein illuminators market are Accuvein, Inc., BLZ Technology, Inc., Cambridge Medical Private Ltd., Christie Medical Holdings, Inc., C.R.Bard, Inc., Infrared Imaging Systems, Inc., Koninklijke Philips N.V., Translite, LLC, Venoscope, LLC and Vuetek Scientific, LLC.
Key Market Movements:
- Increasing number of geriatric and obese patients with different skin tones
- Technological advancement in the hand held vein illuminators with excellent optics, contrast and resolution
- Supportive regulatory environment resulting in positive traction for the vein illuminator market